Filing Details

Accession Number:
0001683168-25-000297
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-13 19:33:16
Reporting Period:
2025-01-09
Accepted Time:
2025-01-13 19:33:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
704562 Avid Bioservices Inc. CDMO Pharmaceutical Preparations (2834) 953698422
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1976193 A. Richard Richieri 14191 Myford Road
Tustin CA 92780
Chief Operations Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2025-01-09 5,507 $0.00 51,818 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2025-01-10 2,283 $12.37 49,535 No 4 S Direct
Common Stock, $0.001 Par Value Acquisiton 2025-01-09 464 $0.00 8,985 No 4 M Indirect By Spouse
Common Stock, $0.001 Par Value Disposition 2025-01-10 200 $12.37 8,785 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2025-01-09 506 $0.00 506 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 946 $0.00 946 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 1,060 $0.00 1,060 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 2,995 $0.00 2,995 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 40 $0.00 40 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 83 $0.00 83 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 132 $0.00 132 $0.00
Common Stock Restricted Stock Units Disposition 2025-01-09 209 $0.00 209 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
64,213 No 4 D Direct
63,267 No 4 D Direct
62,207 No 4 D Direct
59,212 No 4 D Direct
5,241 No 4 D Indirect
5,158 No 4 D Indirect
5,026 No 4 D Indirect
4,817 No 4 D Indirect
Footnotes
  1. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
  2. Represents the shares sold by the reporting person and/or reporting person's spouse pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting and release of the RSUs described in footnotes 3, 4, 5 and 6. This sale does not represent a discretionary trade by the reporting person and/or the reporting person's spouse.
  3. RSUs granted to the reporting person and/or reporting person's spouse on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to continuous service to the Issuer on such vesting dates.
  4. RSUs granted to the reporting person and/or reporting person's spouse on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to continuous service to the Issuer on such vesting dates.
  5. RSUs granted to the reporting person and/or reporting person's spouse on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to continuous service to the Issuer on such vesting dates.
  6. RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2024, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2024, and each quarter thereafter until fully-vested, subject to the reporting person's and/or the reporting person's spouse's continuous service to the Issuer on such vesting dates.